Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

HWEL

Healthwell Acquisition C... (HWEL)

Healthwell Acquisition Corporation I
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:HWEL
DateTimeSourceHeadlineSymbolCompany
18/11/202313:29Business WireHealthwell Acquisition Corp. I Announces Cancellation of Special Stockholder Meeting and its Intention to LiquidateNASDAQ:HWELHealthwell Acquisition Corporation I
04/11/202310:00Business WireHealthwell Acquisition Corp. I Announces Termination of Business Combination with Starton Therapeutics, Inc.NASDAQ:HWELHealthwell Acquisition Corporation I
24/10/202314:55Business WireHealthwell Acquisition Corp. I Announces Postponement of the Special Meeting of Stockholders to Approve the Proposed Business Combination with Starton Therapeutics, Inc. and Related TransactionsNASDAQ:HWELHealthwell Acquisition Corporation I
17/10/202321:00Business WireHealthwell Acquisition Corp. I Announces New Meeting Date for the Special Meeting of Stockholders to Approve Proposed Business Combination With Starton Therapeutics, Inc. and Related TransactionsNASDAQ:HWELHealthwell Acquisition Corporation I
04/10/202323:00Business WireStarton Therapeutics Doses First Patient in Landmark STAR-LLD Lenalidomide Phase 1b Clinical Trial in Multiple MyelomaNASDAQ:HWELHealthwell Acquisition Corporation I
14/09/202306:05Business WireStarton Therapeutics Announces the Opening of the First Clinical Site for STAR-LLD Lenalidomide Phase 1b Trial in Multiple MyelomaNASDAQ:HWELHealthwell Acquisition Corporation I
10/07/202321:00Business WireStarton Therapeutics Contracts Global Clinical Research Organization to Conduct STAR-LLD Phase 1b Clinical Trial in Multiple MyelomaNASDAQ:HWELHealthwell Acquisition Corporation I
24/06/202307:20Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:HWELHealthwell Acquisition Corporation I
14/06/202300:29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HWELHealthwell Acquisition Corporation I
14/06/202300:28Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:HWELHealthwell Acquisition Corporation I
13/06/202306:44Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:HWELHealthwell Acquisition Corporation I
13/06/202306:43Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HWELHealthwell Acquisition Corporation I
13/06/202306:30Business WireStarton Therapeutics Receives Authorization from the FDA to Proceed with STAR-LLD Lenalidomide Phase 1b Clinical Trial in Multiple MyelomaNASDAQ:HWELHealthwell Acquisition Corporation I
08/06/202300:52Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:HWELHealthwell Acquisition Corporation I
06/06/202322:41Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:HWELHealthwell Acquisition Corporation I
06/06/202322:40Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HWELHealthwell Acquisition Corporation I
06/06/202322:00Business WireStarton Therapeutics, Inc. and Healthwell Acquisition Corp. I to Present at the Jefferies Healthcare ConferenceNASDAQ:HWELHealthwell Acquisition Corporation I
19/05/202307:10Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:HWELHealthwell Acquisition Corporation I
16/05/202307:31Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:HWELHealthwell Acquisition Corporation I
16/05/202307:29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HWELHealthwell Acquisition Corporation I
16/05/202306:21Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:HWELHealthwell Acquisition Corporation I
04/05/202307:04Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:HWELHealthwell Acquisition Corporation I
27/04/202321:21Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:HWELHealthwell Acquisition Corporation I
27/04/202321:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HWELHealthwell Acquisition Corporation I
27/04/202321:00Business WireStarton Therapeutics Inc. and Healthwell Acquisition Corp. I to Combine and Create Publicly Traded Leader in Proprietary Continuous Delivery Technology for Cancer TreatmentsNASDAQ:HWELHealthwell Acquisition Corporation I
24/03/202308:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HWELHealthwell Acquisition Corporation I
15/02/202309:42Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:HWELHealthwell Acquisition Corporation I
14/02/202322:08Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:HWELHealthwell Acquisition Corporation I
14/02/202308:02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:HWELHealthwell Acquisition Corporation I
11/02/202309:02Edgar (US Regulatory)

NASDAQ:HWELHealthwell Acquisition Corporation I
 Showing the most relevant articles for your search:NASDAQ:HWEL